Genital Herpes Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: G73ED98F6C8DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Genital Herpes Treatment in Global, including the following market information:

Global Genital Herpes Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Genital Herpes Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Acyclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Genital Herpes Treatment include Teva, Abbott, Sun, Mylan, Pfizer, GlaxoSmithKline, Dr. Reddy's, Novartis and Valeant. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genital Herpes Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Genital Herpes Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Genital Herpes Treatment Market Segment Percentages, by Type, 2021 (%)

• Acyclovir
• Valacyclovir
• Famciclovir

Global Genital Herpes Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Genital Herpes Treatment Market Segment Percentages, by Application, 2021 (%)

• HSV-1
• HSV-2

Global Genital Herpes Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Genital Herpes Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Genital Herpes Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Genital Herpes Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• Abbott
• Sun
• Mylan
• Pfizer
• GlaxoSmithKline
• Dr. Reddy's
• Novartis
• Valeant

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Genital Herpes Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Genital Herpes Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENITAL HERPES TREATMENT OVERALL MARKET SIZE

2.1 Global Genital Herpes Treatment Market Size: 2021 VS 2028
2.2 Global Genital Herpes Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Genital Herpes Treatment Players in Global Market
3.2 Top Global Genital Herpes Treatment Companies Ranked by Revenue
3.3 Global Genital Herpes Treatment Revenue by Companies
3.4 Top 3 and Top 5 Genital Herpes Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genital Herpes Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genital Herpes Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Genital Herpes Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Genital Herpes Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Genital Herpes Treatment Market Size Markets, 2021 & 2028
  4.1.2 Acyclovir
  4.1.3 Valacyclovir
  4.1.4 Famciclovir
4.2 By Type - Global Genital Herpes Treatment Revenue & Forecasts
  4.2.1 By Type - Global Genital Herpes Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Genital Herpes Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Genital Herpes Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Genital Herpes Treatment Market Size, 2021 & 2028
  5.1.2 HSV-1
  5.1.3 HSV-2
5.2 By Application - Global Genital Herpes Treatment Revenue & Forecasts
  5.2.1 By Application - Global Genital Herpes Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Genital Herpes Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Genital Herpes Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Genital Herpes Treatment Market Size, 2021 & 2028
6.2 By Region - Global Genital Herpes Treatment Revenue & Forecasts
  6.2.1 By Region - Global Genital Herpes Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Genital Herpes Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Genital Herpes Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Genital Herpes Treatment Revenue, 2017-2028
  6.3.2 US Genital Herpes Treatment Market Size, 2017-2028
  6.3.3 Canada Genital Herpes Treatment Market Size, 2017-2028
  6.3.4 Mexico Genital Herpes Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Genital Herpes Treatment Revenue, 2017-2028
  6.4.2 Germany Genital Herpes Treatment Market Size, 2017-2028
  6.4.3 France Genital Herpes Treatment Market Size, 2017-2028
  6.4.4 U.K. Genital Herpes Treatment Market Size, 2017-2028
  6.4.5 Italy Genital Herpes Treatment Market Size, 2017-2028
  6.4.6 Russia Genital Herpes Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Genital Herpes Treatment Market Size, 2017-2028
  6.4.8 Benelux Genital Herpes Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Genital Herpes Treatment Revenue, 2017-2028
  6.5.2 China Genital Herpes Treatment Market Size, 2017-2028
  6.5.3 Japan Genital Herpes Treatment Market Size, 2017-2028
  6.5.4 South Korea Genital Herpes Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Genital Herpes Treatment Market Size, 2017-2028
  6.5.6 India Genital Herpes Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Genital Herpes Treatment Revenue, 2017-2028
  6.6.2 Brazil Genital Herpes Treatment Market Size, 2017-2028
  6.6.3 Argentina Genital Herpes Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Genital Herpes Treatment Revenue, 2017-2028
  6.7.2 Turkey Genital Herpes Treatment Market Size, 2017-2028
  6.7.3 Israel Genital Herpes Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Genital Herpes Treatment Market Size, 2017-2028
  6.7.5 UAE Genital Herpes Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva
  7.1.1 Teva Corporate Summary
  7.1.2 Teva Business Overview
  7.1.3 Teva Genital Herpes Treatment Major Product Offerings
  7.1.4 Teva Genital Herpes Treatment Revenue in Global Market (2017-2022)
  7.1.5 Teva Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott Genital Herpes Treatment Major Product Offerings
  7.2.4 Abbott Genital Herpes Treatment Revenue in Global Market (2017-2022)
  7.2.5 Abbott Key News
7.3 Sun
  7.3.1 Sun Corporate Summary
  7.3.2 Sun Business Overview
  7.3.3 Sun Genital Herpes Treatment Major Product Offerings
  7.3.4 Sun Genital Herpes Treatment Revenue in Global Market (2017-2022)
  7.3.5 Sun Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan Genital Herpes Treatment Major Product Offerings
  7.4.4 Mylan Genital Herpes Treatment Revenue in Global Market (2017-2022)
  7.4.5 Mylan Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Genital Herpes Treatment Major Product Offerings
  7.5.4 Pfizer Genital Herpes Treatment Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Genital Herpes Treatment Major Product Offerings
  7.6.4 GlaxoSmithKline Genital Herpes Treatment Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Dr. Reddy's
  7.7.1 Dr. Reddy's Corporate Summary
  7.7.2 Dr. Reddy's Business Overview
  7.7.3 Dr. Reddy's Genital Herpes Treatment Major Product Offerings
  7.7.4 Dr. Reddy's Genital Herpes Treatment Revenue in Global Market (2017-2022)
  7.7.5 Dr. Reddy's Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Genital Herpes Treatment Major Product Offerings
  7.8.4 Novartis Genital Herpes Treatment Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Valeant
  7.9.1 Valeant Corporate Summary
  7.9.2 Valeant Business Overview
  7.9.3 Valeant Genital Herpes Treatment Major Product Offerings
  7.9.4 Valeant Genital Herpes Treatment Revenue in Global Market (2017-2022)
  7.9.5 Valeant Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Genital Herpes Treatment Market Opportunities & Trends in Global Market
Table 2. Genital Herpes Treatment Market Drivers in Global Market
Table 3. Genital Herpes Treatment Market Restraints in Global Market
Table 4. Key Players of Genital Herpes Treatment in Global Market
Table 5. Top Genital Herpes Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Genital Herpes Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Genital Herpes Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Genital Herpes Treatment Product Type
Table 9. List of Global Tier 1 Genital Herpes Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genital Herpes Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Genital Herpes Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Genital Herpes Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Genital Herpes Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Genital Herpes Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Genital Herpes Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Genital Herpes Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Genital Herpes Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Genital Herpes Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Genital Herpes Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Genital Herpes Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Genital Herpes Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Genital Herpes Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Genital Herpes Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Genital Herpes Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Genital Herpes Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Genital Herpes Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Genital Herpes Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Genital Herpes Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Genital Herpes Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Teva Corporate Summary
Table 31. Teva Genital Herpes Treatment Product Offerings
Table 32. Teva Genital Herpes Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott Genital Herpes Treatment Product Offerings
Table 35. Abbott Genital Herpes Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sun Corporate Summary
Table 37. Sun Genital Herpes Treatment Product Offerings
Table 38. Sun Genital Herpes Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Mylan Corporate Summary
Table 40. Mylan Genital Herpes Treatment Product Offerings
Table 41. Mylan Genital Herpes Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Genital Herpes Treatment Product Offerings
Table 44. Pfizer Genital Herpes Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Genital Herpes Treatment Product Offerings
Table 47. GlaxoSmithKline Genital Herpes Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Dr. Reddy's Corporate Summary
Table 49. Dr. Reddy's Genital Herpes Treatment Product Offerings
Table 50. Dr. Reddy's Genital Herpes Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Genital Herpes Treatment Product Offerings
Table 53. Novartis Genital Herpes Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Valeant Corporate Summary
Table 55. Valeant Genital Herpes Treatment Product Offerings
Table 56. Valeant Genital Herpes Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Genital Herpes Treatment Segment by Type in 2021
Figure 2. Genital Herpes Treatment Segment by Application in 2021
Figure 3. Global Genital Herpes Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Genital Herpes Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Genital Herpes Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genital Herpes Treatment Revenue in 2021
Figure 8. By Type - Global Genital Herpes Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Genital Herpes Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Genital Herpes Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Genital Herpes Treatment Revenue Market Share, 2017-2028
Figure 12. US Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Genital Herpes Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Genital Herpes Treatment Revenue Market Share, 2017-2028
Figure 24. China Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Genital Herpes Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Genital Herpes Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Genital Herpes Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Genital Herpes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Genital Herpes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sun Genital Herpes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan Genital Herpes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Genital Herpes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Genital Herpes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dr. Reddy's Genital Herpes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Genital Herpes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Valeant Genital Herpes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)